Overview
Laparoscopic cholecystectomy is generally a low-to-moderate pain procedure, but pain can be multidimensional and harder to treat than the small incisions suggest — combining incisional (port-site), visceral (gallbladder bed, biliary manipulation), and a distinctive referred shoulder pain component related to pneumoperitoneum. PROSPECT 2024 represents a substantial update with 157 RCTs and 31 systematic reviews reviewed (Aug 2017–Dec 2022).
PROSPECT 2024 summary: Paracetamol + NSAID/COX-2 pre- or intraoperatively. IV dexamethasone, port-site wound infiltration, and/or intraperitoneal local anaesthetic instillation recommended. ESP block or TAP block as second-line regional techniques, reserved for patients at heightened risk of pain. Several surgical technique factors (3-port vs 4-port, low-pressure pneumoperitoneum) also reduce pain. Opioids for rescue.
The Shoulder Pain Phenomenon
A distinctive feature of laparoscopic cholecystectomy is referred shoulder-tip pain, distinct from the abdominal incisional/visceral pain and often poorly responsive to standard systemic analgesia. The mechanism involves:
- Phrenic nerve irritation — diaphragmatic stretching and residual CO₂ causes referred pain via the phrenic nerve (C3–C5), perceived in the shoulder due to shared dermatomal origin
- Peritoneal stretching — pneumoperitoneum distends the peritoneum, contributing to diffuse abdominal and referred pain
- CO₂-induced acidosis — residual carbonic acid formation on the peritoneal surface is thought to contribute to peritoneal irritation
This explains why surgical technique factors that reduce CO₂ retention (low-pressure pneumoperitoneum, active gas aspiration at the end of surgery, saline lavage) have a specific evidence base for reducing shoulder pain — distinct from and additional to standard analgesic interventions targeting incisional pain.
Analgesic Pathway
- Paracetamol 1g PO
- NSAID or COX-2 inhibitor PO
- Dexamethasone 8 mg IV
- Port-site wound infiltration (LA)
- Intraperitoneal LA instillation (gallbladder bed/subdiaphragmatic)
- Paracetamol 1g IV (if not given pre-op)
- Low-pressure pneumoperitoneum (<12 mmHg)
- 3-port technique preferred over 4-port
- Active aspiration of pneumoperitoneum + saline lavage at end
- ESP or TAP block — second-line, high-pain-risk patients only
- Paracetamol 1g QDS regular
- NSAID/COX-2 regular ≤5 days
- Opioid PRN rescue
- Early mobilisation — often same-day discharge
✓ Recommended | ◎ Optional/conditional. Based on PROSPECT 2024 (Barazanchi et al. update).
Systemic Analgesia
Paracetamol combined with NSAID or COX-2 inhibitor, given pre- or intraoperatively unless contraindicated, forms the basic foundation. IV dexamethasone is specifically recommended as an additional intraoperative adjunct — providing analgesia, PONV prophylaxis (particularly valuable given the high baseline PONV risk with laparoscopic/pneumoperitoneum surgery), and supporting same-day discharge goals.
| Agent | Dose | Route | Frequency | Notes |
|---|---|---|---|---|
| Paracetamol | 1 g | IV/PO | QDS | Regular throughout |
| Celecoxib | 200 mg | PO | BD | COX-2 preferred; ≤5 days |
| Ibuprofen | 400 mg | PO | TDS | Non-selective alternative |
| Dexamethasone | 8 mg | IV | Single intraop | Analgesia + strong PONV prophylaxis — important for day-case |
| Oxycodone/Tramadol | Titrated | PO/IV PRN | PRN | Rescue analgesia; most patients need minimal opioid |
Port-Site & Intraperitoneal Local Anaesthetic
Local infiltration analgesia (port-site ± intraperitoneal instillation) is the most consistently and strongly recommended intervention across successive PROSPECT cholecystectomy guidelines — simple, low-risk, and effective. Both port-site infiltration and intraperitoneal instillation (onto the gallbladder bed/subdiaphragmatic area, targeting the source of referred shoulder pain) have supporting evidence; combining both is common practice.
Technique
Port-site infiltration: LA infiltrated into the subcutaneous tissue and fascia at each port site, performed by the surgeon before or after trocar insertion/removal.
Intraperitoneal instillation: LA instilled directly onto the gallbladder bed and right subdiaphragmatic space at the end of the procedure, under laparoscopic vision, aiming to reduce both visceral and referred shoulder pain.
Dosing
| Technique | Agent | Concentration | Volume |
|---|---|---|---|
| Port-site infiltration | Ropivacaine or Bupivacaine | 0.25–0.5% | 5–10 mL per port (4 ports typical) |
| Intraperitoneal instillation | Ropivacaine or Bupivacaine | 0.25% | 20–30 mL onto gallbladder bed/subdiaphragm |
Calculate total combined LA dose (port-site + intraperitoneal) against patient weight before administration.
Second-Line Regional Blocks
ESP block or TAP block may be considered as second-line options — not for routine use in all patients, but reserved for those with risk factors for increased postoperative pain (e.g. chronic pain history, opioid tolerance, anxiety, anticipated difficult surgery/conversion risk).
See the TAP block page for full technique details; subcostal approach is typically used given the upper abdominal port placement in cholecystectomy. Bilateral subcostal TAP, ropivacaine 0.375% 15–20 mL per side, is a reasonable choice when indicated.
Surgical Technique Factors
Surgical technique meaningfully affects pain in laparoscopic cholecystectomy, independent of the analgesic regimen — reflecting the shoulder-pain mechanism described above.
| Factor | Recommendation | Rationale |
|---|---|---|
| Number of ports | 3-port preferred over 4-port | Fewer incisions = less incisional pain |
| Pneumoperitoneum pressure | Low-pressure (<12 mmHg) | Less peritoneal stretch and diaphragmatic irritation → less shoulder pain |
| Port extraction site | Umbilical preferred | Associated with less pain than alternative sites |
| End-of-procedure gas management | Active aspiration of pneumoperitoneum | Reduces residual CO₂ → less phrenic irritation/shoulder pain |
| Saline irrigation | Recommended | Washes out residual blood/bile, reduces peritoneal irritation |
Not Recommended
Despite cosmetic appeal, no evidence of reduced postoperative pain compared with standard multi-port technique.
No pain benefit from routine surgical drain placement; adds discomfort without analgesic advantage.
Insufficient evidence of pain benefit for these alternative technical approaches.
Insufficient evidence to support routine use as analgesic adjuncts for this procedure.
Despite use in other abdominal procedures, insufficient procedure-specific evidence for laparoscopic cholecystectomy to support routine recommendation over the established first-line approach (port-site/intraperitoneal LA).
Practical Analgesic Protocol
Suggested protocol for elective day-case laparoscopic cholecystectomy:
References
- PROSPECT Working Group (Barazanchi et al. update). Pain management after laparoscopic cholecystectomy: a systematic review and PROSPECT recommendations. Eur J Anaesthesiol. 2024. PMID 39129451 ↗
- Barazanchi AWH, MacFater WS, Rahiri JL, et al. Evidence-based management of pain after laparoscopic cholecystectomy: a PROSPECT review update. Br J Anaesth. 2018;121(4):787–803.
- The Role of Surgical Techniques in Reducing Postoperative Pain in Abdominal Surgery: Evidence From the PROSPECT Systematic Reviews. 2025. PMC12582144 ↗
- Kehlet H, Gray AW, Bonnet F, et al. A procedure-specific systematic review and consensus recommendations for postoperative analgesia following laparoscopic cholecystectomy. Surg Endosc. 2005;19:1396–1415.